MBL International Corporation is a leading life science company focused on providing high-quality products and solutions for life science research and clinical diagnostics.
Established in 1993 as a subsidiary of Medical and Biological Laboratories Co. Ltd, Nagoya, Japan, MBL International Corporation develops, manufactures and markets a wide range of ELISA and IFA test kits to aid in the diagnosis of autoimmune and infectious disease as well as an extensive portfolio of monoclonal and polyclonal antibodies, fluorescent and recombinant proteins, and ELISA kits for research related to allergy, apoptosis, autophagy, cancer, epigenetics, immunology, and neuroscience.
Our products are used widely in academic research institutions, pharmaceutical and biotechnology companies, government agencies, as well as hospital and reference laboratories. By providing a consultative approach, superior technical and customer support, and convenient purchasing options, MBL International Corporation partners with our customers to solve their scientific and clinical challenges. Learn More »
Recent Brochures and Application Notes
Smart-IP AntibodiesSmart-IP is a line of highly specific tag antibodies
conjugated to magnetic beads or magnetic agarose
beads designed for faster immunoprecipitation.